Cipla gained on Wednesday after the Meditab Holdings, Mauritius, a wholly owned subsidiary of the company, has entered into a definitive agreement to sell its entire 48.22% equity interest in Jiangsu Cdymax Pharmaceuticals Co., China (Jiangsu) to an affiliate of one of the other shareholders of Jiangsu, for a total consideration of USD 18.5 million.

The closing of the transaction is subject to receipt of applicable regulatory approvals in China.

Shares of the company gained Rs 5.9, or 0.92%, to trade at Rs 645.75. The total volume of shares traded was 34,196 at the BSE (11.12 a.m., Wednesday).

The scrip has touched an intra-day high of Rs 651 and low of Rs 637.40. The total volume of shares traded at the BSE is 34,196.